Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $40.26 million. The enterprise value is $25.26 million.
Important Dates
The next estimated earnings date is Monday, May 19, 2025.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 41.08 million shares outstanding. The number of shares has increased by 2.48% in one year.
| Current Share Class | 41.08M |
| Shares Outstanding | 41.08M |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +5.72% |
| Owned by Insiders (%) | 40.54% |
| Owned by Institutions (%) | 3.31% |
| Float | 3.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.69 |
| P/TBV Ratio | 2.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.52
| Current Ratio | 17.52 |
| Quick Ratio | 17.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.52 |
Financial Efficiency
Return on equity (ROE) is -71.49% and return on invested capital (ROIC) is -46.65%.
| Return on Equity (ROE) | -71.49% |
| Return on Assets (ROA) | -42.87% |
| Return on Invested Capital (ROIC) | -46.65% |
| Return on Capital Employed (ROCE) | -53.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.56M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.45% in the last 52 weeks. The beta is -1.13, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -1.13 |
| 52-Week Price Change | -66.45% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 37.34 |
| Average Volume (20 Days) | 12,037 |
Short Selling Information
The latest short interest is 33,590, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 33,590 |
| Short Previous Month | 45,564 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 1.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.00M |
| Pretax Income | -9.35M |
| Net Income | -7.67M |
| EBITDA | n/a |
| EBIT | -8.00M |
| Earnings Per Share (EPS) | -$0.29 |
Full Income StatementBalance Sheet
The company has $15.00 million in cash and n/a in debt, giving a net cash position of $15.00 million or $0.37 per share.
| Cash & Cash Equivalents | 15.00M |
| Total Debt | n/a |
| Net Cash | 15.00M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 14.96M |
| Book Value Per Share | 0.36 |
| Working Capital | 14.52M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |